BRG: Reset Expectations And Buybacks Will Support Future Earnings Reappraisal

Borregaard's analyst price target has been revised to NOK 174 from NOK 183.80, as analysts factor in slightly lower revenue growth and profit margin assumptions, alongside a modestly reduced future P/E multiple. They view much of the recent "bad news" as already reflected in the stock.

Analyst Commentary

Recent research on Borregaard reflects a more constructive tone, with several bullish analysts indicating that much of the recent bad news is already reflected in the stock and in current valuation assumptions.

Bullish Takeaways

Bullish analysts argue that the recent reset in expectations, including lower revenue growth and margin assumptions, gives Borregaard more room to positively surprise if execution is solid.
The view that most of the bad news is already priced in supports the idea that current valuation multiples, including the reduced future P/E, may already reflect more cautious scenarios.
Upgrades accompanied by price targets in the NOK 160s suggest that some analysts see upside potential relative to where they believe sentiment has been pricing the stock.
Analysts who are turning more positive see any improvement in operational delivery or cost control as a possible catalyst for a reassessment of Borregaard's earnings power.

Bearish Takeaways

Even with upgrades, analysts remain mindful that the revised targets factor in lower revenue growth and profit margins, which limits how aggressively they are willing to value Borregaard.
Some cautious analysts may see the trimmed future P/E multiple as a sign that investors still require evidence of consistent execution before assigning a higher valuation.
The reliance on the idea that bad news is largely behind the company can be a risk if new operational or market issues arise that are not currently reflected in forecasts.
Upgrades following a period of weaker sentiment may leave limited room for further positive revisions without clear proof points on earnings quality and cash generation.

What’s in the News for Borregaard

Borregaard ASA has commenced a share repurchase program from May 11, 2026, under a mandate from the April 16, 2026 Annual General Meeting, allowing buybacks of up to 9,994,413 shares, equal to 10% of its outstanding share capital.
The authorization permits repurchases at prices between NOK 1 and NOK 400 per share. The program is valid until the 2027 Annual General Meeting, and no later than June 30, 2027.
Repurchased Borregaard shares can be used for employee share and other incentive schemes, and may also be used for amortization of share capital.
On May 8, 2026, Borregaard announced a separate share repurchase program of 300,000 shares at a maximum price of NOK 400 per share, to be conducted between May 11, 2026 and June 18, 2026. The shares are intended for employee incentive programs.
As of March 25, 2026, Borregaard reported 99,944,133 shares in issue excluding treasury shares, and 55,867 shares held in treasury, providing context for the scale of the authorized buybacks.

Valuation Changes for Borregaard

Fair Value: NOK 174.0, down from NOK 183.8. This indicates a modest reduction in the central valuation estimate.
Discount Rate: 6.98%, slightly lower than the previous 7.02%. This reflects a small adjustment in the required rate of return.
Revenue Growth: 4.42%, reduced from 4.82%. This points to more cautious long term top line assumptions for Borregaard.
Net Profit Margin: 15.59%, marginally lower than 15.73%. This implies only a limited change in expected profitability.
Future P/E: 15.62x, trimmed from 16.19x. This suggests a slightly more conservative multiple applied to Borregaard's earnings outlook.

0 views

Key Takeaways

Strong demand for green products and high-value specialties is expected to boost sales and margins, driving revenue growth for Borregaard.
Operational improvements and currency hedging could stabilize revenue and enhance financial resilience despite trade and currency challenges.
Trade tensions and increased expenses could affect Borregaard's revenue and margins, while reliance on agriculture exposes it to sector-specific risks.

Catalysts

About Borregaard

Engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.What are the underlying business or industry changes driving this perspective?

Strong sales in the agriculture segment, driven by the increasing demand for green and biocontrol products, are expected to positively impact revenue growth and EBITDA margins.
The favorable product mix in BioSolutions, particularly with high-value specialty products, is anticipated to boost overall earnings and contribute to higher net margins.
Tariffs and trade dynamics, although presenting some uncertainty, might have less impact on Borregaard due to its highly specialized products and diverse market presence, thereby potentially stabilizing revenue despite global trade fluctuations.
Continuous investment and focus on operational improvements, such as the electrification of biopolymer spray dryers to reduce energy costs, are likely to enhance net margins over time.
Ongoing currency hedging strategies and anticipated positive currency effects are expected to have a favorable impact on EBITDA and earnings, providing financial resilience amidst currency volatility.

Borregaard Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Borregaard's revenue will grow by 4.4% annually over the next 3 years.
Analysts assume that profit margins will increase from 7.2% today to 15.6% in 3 years time.
Analysts expect earnings to reach NOK 1.4 billion (and earnings per share of NOK 11.13) by about June 2029, up from NOK 551.0 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as NOK837.7 million.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 15.7x on those 2029 earnings, down from 26.6x today. This future PE is lower than the current PE for the GB Chemicals industry at 26.6x.
Analysts expect the number of shares outstanding to grow by 0.22% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 6.98%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

The introduction of a 10% tariff on imports from Norway into the U.S. could impact Borregaard's revenues from their U.S. sales, as 10% of their sales last year came from Norway to the U.S. The lower volume of exports due to these tariffs might have a negative effect on revenue.
Increased supply of advanced bioethanol in Europe, based on agricultural waste, is expected to lead to significantly lower sales prices for Borregaard's bioethanol, which could decrease revenue and impact net margins in the Fine Chemicals segment.
Higher wood and logistical costs have increased expenses for Borregaard, which could limit the company's ability to increase net margins and impact overall profitability.
Potential negative effects on global GDP growth from tariffs and trade tensions could ultimately reduce demand for Borregaard's products, affecting revenue growth across its segments.
The strong current reliance on the agricultural sector for BioSolutions' revenues might expose Borregaard to risks associated with any downturn in agriculture or shifts in customer demand, potentially impacting revenues and earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of NOK174.0 for Borregaard based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of NOK196.0, and the most bearish reporting a price target of just NOK160.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be NOK8.7 billion, earnings will come to NOK1.4 billion, and it would be trading on a PE ratio of 15.7x, assuming you use a discount rate of 7.0%.
Given the current share price of NOK146.4, the analyst price target of NOK174.0 is 15.9% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Borregaard?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments